A semi-automated luminescence based standard membrane feeding assay identifies novel small molecules that inhibit transmission of malaria parasites by mosquitoes
暂无分享,去创建一个
Teun Bousema | Robert W. Sauerwein | Koen J. Dechering | Geert-Jan van Gemert | Didier Leroy | T. Bousema | K. Dechering | G. van Gemert | D. Leroy | R. Sauerwein | Ben C. L. van Schaijk | Ben van Schaijk | Karin M. J. Koolen | Martijn W. Vos | Will J. R. Stone | Karin M. Koolen | K. M. Koolen | W. Stone
[1] C. Janse,et al. Removal of Heterologous Sequences from Plasmodium falciparum Mutants Using FLPe-Recombinase , 2010, PloS one.
[2] R. Sheaff,et al. Luciferase inhibition by a novel naphthoquinone. , 2012, Journal of photochemistry and photobiology. B, Biology.
[3] R. Sinden,et al. A high-throughput assay for the identification of malarial transmission-blocking drugs and vaccines. , 2012, International journal for parasitology.
[4] Teun Bousema,et al. Epidemiology and Infectivity of Plasmodium falciparum and Plasmodium vivax Gametocytes in Relation to Malaria Control and Elimination , 2011, Clinical Microbiology Reviews.
[5] A. Vaughan,et al. A scalable assessment of Plasmodium falciparum transmission in the standard membrane-feeding assay, using transgenic parasites expressing green fluorescent protein-luciferase. , 2014, Journal of Infectious Diseases.
[6] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[7] J. Meuwissen,et al. Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes , 1989, Parasitology.
[8] S. Hay,et al. The decline in paediatric malaria admissions on the coast of Kenya , 2007, Malaria Journal.
[9] P. Garner,et al. Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission , 2014, The Cochrane database of systematic reviews.
[10] Farah El Mazouni,et al. A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria , 2015, Science Translational Medicine.
[11] N. White. Primaquine to prevent transmission of falciparum malaria. , 2013, The Lancet. Infectious diseases.
[12] D. Fidock,et al. Identification of MMV Malaria Box Inhibitors of Plasmodium falciparum Early-Stage Gametocytes Using a Luciferase-Based High-Throughput Assay , 2013, Antimicrobial Agents and Chemotherapy.
[13] D. Sullivan,et al. Gametocytocidal Screen Identifies Novel Chemical Classes with Plasmodium falciparum Transmission Blocking Activity , 2014, PloS one.
[14] D. Fidock,et al. Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Meuwissen,et al. Cultivation of fertile Plasmodium falciparum gametocytes in semi-automated systems. 1. Static cultures. , 1982, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[16] R. Sinden,et al. Male and Female Plasmodium falciparum Mature Gametocytes Show Different Responses to Antimalarial Drugs , 2013, Antimicrobial Agents and Chemotherapy.
[17] K. Matuschewski,et al. High efficiency transfection of Plasmodium berghei facilitates novel selection procedures. , 2006, Molecular and biochemical parasitology.
[18] David W. Gray,et al. A novel multiple-stage antimalarial agent that inhibits protein synthesis , 2015, Nature.
[19] D. Han,et al. KRIBB11 Inhibits HSP70 Synthesis through Inhibition of Heat Shock Factor 1 Function by Impairing the Recruitment of Positive Transcription Elongation Factor b to the hsp70 Promoter* , 2010, The Journal of Biological Chemistry.
[20] T. Triglia,et al. Negative selection of Plasmodium falciparum reveals targeted gene deletion by double crossover recombination. , 2002, International journal for parasitology.
[21] Jeremy N. Burrows,et al. P. falciparum In Vitro Killing Rates Allow to Discriminate between Different Antimalarial Mode-of-Action , 2012, PloS one.
[22] Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination , 2014, Parasitology Research.
[23] R. Rosenberg. Malaria: some considerations regarding parasite productivity. , 2008, Trends in parasitology.
[24] Koen J. Dechering,et al. Isolation and Functional Characterization of Two Distinct Sexual-Stage-Specific Promoters of the Human Malaria Parasite Plasmodium falciparum , 1999, Molecular and Cellular Biology.
[25] J. Burrows,et al. Designing the next generation of medicines for malaria control and eradication , 2013, Malaria Journal.
[26] Manuel Llinás,et al. Comparative whole genome transcriptome analysis of three Plasmodium falciparum strains , 2006, Nucleic acids research.
[27] N. White. The role of anti-malarial drugs in eliminating malaria , 2008, Malaria Journal.
[28] T. Bousema,et al. Rationale for short course primaquine in Africa to interrupt malaria transmission , 2012, Malaria Journal.
[29] J. Sattabongkot,et al. Population dynamics of sporogony for Plasmodium vivax parasites from western Thailand developing within three species of colonized Anopheles mosquitoes , 2006, Malaria Journal.
[30] I. Gluzman,et al. A set of independent selectable markers for transfection of the human malaria parasite Plasmodium falciparum. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[31] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[32] K. Williamson,et al. A malaria gametocytocidal assay using oxidoreduction indicator, alamarBlue. , 2011, Molecular and biochemical parasitology.
[33] Timothy N. C. Wells,et al. Malaria medicines: a glass half full? , 2015, Nature Reviews Drug Discovery.
[34] E. Winzeler,et al. The Activities of Current Antimalarial Drugs on the Life Cycle Stages of Plasmodium: A Comparative Study with Human and Rodent Parasites , 2012, PLoS medicine.
[35] R. Sinden,et al. Measuring the blockade of malaria transmission--an analysis of the Standard Membrane Feeding Assay. , 2012, International journal for parasitology.
[36] R. Sinden,et al. A Male and Female Gametocyte Functional Viability Assay To Identify Biologically Relevant Malaria Transmission-Blocking Drugs , 2014, Antimicrobial Agents and Chemotherapy.
[37] Silvia Parapini,et al. A Plasmodium falciparum screening assay for anti-gametocyte drugs based on parasite lactate dehydrogenase detection. , 2013, The Journal of antimicrobial chemotherapy.
[38] A. Cowman,et al. Negative selection using yeast cytosine deaminase/uracil phosphoribosyl transferase in Plasmodium falciparum for targeted gene deletion by double crossover recombination. , 2006, Molecular and biochemical parasitology.
[39] V. Navratil,et al. Identifying genomic changes associated with insecticide resistance in the dengue mosquito Aedes aegypti by deep targeted sequencing , 2015, Genome research.
[40] P. Gething,et al. Lead Clinical and Preclinical Antimalarial Drugs Can Significantly Reduce Sporozoite Transmission to Vertebrate Populations , 2014, Antimicrobial Agents and Chemotherapy.
[41] Teun Bousema,et al. Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs , 2010 .
[42] T. Bousema,et al. The relevance and applicability of oocyst prevalence as a read-out for mosquito feeding assays , 2013, Scientific Reports.
[43] M. Cassera,et al. Antiapicoplast and Gametocytocidal Screening To Identify the Mechanisms of Action of Compounds within the Malaria Box , 2013, Antimicrobial Agents and Chemotherapy.
[44] V. Avery,et al. Identification of inhibitors of Plasmodium falciparum gametocyte development , 2013, Malaria Journal.
[45] J. Vanderberg,et al. Complete in vitro maturation of Plasmodium falciparum gametocytes , 1981, Nature.
[46] T. Bousema,et al. A combination of new screening assays for prioritization of transmission-blocking antimalarials reveals distinct dynamics of marketed and experimental drugs. , 2015, The Journal of antimicrobial chemotherapy.
[47] C. Siethoff,et al. First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials , 2012, British journal of clinical pharmacology.
[48] A. Vaughan,et al. A transgenic Plasmodium falciparum NF54 strain that expresses GFP-luciferase throughout the parasite life cycle. , 2012, Molecular and biochemical parasitology.
[49] Teun Bousema,et al. Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials , 2008, Malaria Journal.
[50] Mollie E. Brooks,et al. Generalized linear mixed models: a practical guide for ecology and evolution. , 2009, Trends in ecology & evolution.
[51] G. Butcher. Antimalarial drugs and the mosquito transmission of Plasmodium. , 1997, International journal for parasitology.
[52] Robert W. Sauerwein,et al. Targeting Plasmodium PI(4)K to eliminate malaria , 2013, Nature.
[53] R. Rosenberg,et al. The number of sporozoites produced by individual malaria oocysts. , 1991, The American journal of tropical medicine and hygiene.
[54] Jeremy N. Burrows,et al. The Open Access Malaria Box: A Drug Discovery Catalyst for Neglected Diseases , 2013, PloS one.
[55] D. Mancama,et al. Nowhere to hide: interrogating different metabolic parameters of Plasmodium falciparum gametocytes in a transmission blocking drug discovery pipeline towards malaria elimination , 2015, Malaria Journal.
[56] T. Bousema,et al. Substantial Contribution of Submicroscopical Plasmodium falciparum Gametocyte Carriage to the Infectious Reservoir in an Area of Seasonal Transmission , 2009, PloS one.
[57] J. McCarthy,et al. Effect of antimalarial drugs on Plasmodium falciparum gametocytes. , 2009, The Journal of infectious diseases.
[58] W. Milhous,et al. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[59] P Garner,et al. Artesunate combinations for treatment of malaria: meta-analysis , 2004, The Lancet.
[60] E. Fikrig,et al. Anopheles gambiae circumsporozoite protein-binding protein facilitates plasmodium infection of mosquito salivary glands. , 2013, The Journal of infectious diseases.
[61] R. Sinden,et al. Persistence of atovaquone in human sera following treatment: inhibition of Plasmodium falciparum development in vivo and in vitro. , 2003, The American journal of tropical medicine and hygiene.
[62] Isabel Rodriguez-Barraquer,et al. Robust, reproducible, industrialized, standard membrane feeding assay for assessing the transmission blocking activity of vaccines and drugs against Plasmodium falciparum , 2015, Malaria Journal.